NDC 16729-078-10 - CARBIDOPA AND LEVODOPA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-078
- Requested NDC
- 16729-078-10
- Package NDCs from labels
- 16729-078-10, 16729-078-01, 16729-078-16, 16729-078-17
- Manufacturer
- Accord Healthcare, Inc. | Intas Pharmaceuticals Ltd
- Effective date
- 2026-11-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CARBIDOPA AND LEVODOPA - Accord Healthcare, Inc. | Intas Pharmaceuticals Ltd | Accord Healthcare, Inc. | Intas Pharmaceuticals Ltd | 2026-11-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-078-01 | CARBIDOPA AND LEVODOPA | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 11 | |
| 16729-078-10 | CARBIDOPA AND LEVODOPA | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 11 | |
| 16729-078-16 | CARBIDOPA AND LEVODOPA | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | 11 | |
| 16729-078-17 | CARBIDOPA AND LEVODOPA | 1000 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 1000 | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-078-01 | EA - Each | 16729-078 | 85565135-8035-499c-b8c8-bcd53f4ddb97 | 1 | 2013-07-02 |
| 16729-078-17 | EA - Each | 16729-078 | 03ccd1ff-3f11-4abf-95c9-b59e14ab6ac3 | 1 | 2013-08-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Accord Healthcare, Inc. | 5217a6ec-cc26-4acc-b2da-17f6545c3b60 | 2026-11-06 | Warnings, Adverse reactions | ANDA202323 16729-078-17 16729-078-01 16729-079-10 16729-078-10 16729-079-01 16729-079-17 16729-079-16 16729-078-16 16729-079 16729-078 16729007810 308988 308989 5f9d3c46-cfda-e58c-e063-6294a90a87ab 5217a6ec-cc26-4acc-b2da-17f6545c3b60 MNX7R8C5VO 46627O600J |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | AmerisourceBergen Drug Corporation | f161e151-4fab-2fbc-e053-2a95a90a5437 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | HY-VEE, INC | 415ecfe9-3145-f23e-e063-6394a90adfd8 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Meijer Distribution Inc. | 03c46823-0b1f-4101-e063-6294a90aaf94 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO TOUCH SPRAY | Premier Brands of America Inc. | 36481d67-2346-470b-e063-6294a90aae99 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Chain Drug Marketing Association Inc | 1a3f8819-58cf-8923-e063-6394a90a37af | 2026-11-04 | Warnings | 1K09F3G675 |
| Carbidopa-levodopa | CARBIDOPA AND LEVODOPA | TruPharma, LLC | d1bb319b-82a3-4b66-9cdc-f77fdb8383ce | 2026-11-02 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and levodopa | CARBIDOPA AND LEVODOPA | Teva Pharmaceuticals USA, Inc. | 4ace5274-b6cf-414c-b9c0-f60e28a9cea5 | 2026-09-30 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa-levodopa | CARBIDOPA AND LEVODOPA | Advagen Pharma Ltd., | 9e3c796b-2e68-4bcc-b927-18a58bea4703 | 2026-09-25 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Topco Associates LLC | af314adb-bd65-4233-b7e1-6cfb819615a3 | 2026-09-25 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO-TOUCH | Walgreens Company | 33219878-f102-46c6-bd63-e83d54fa2785 | 2026-09-25 | Warnings | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXIND HCL | Nice-Pak Products, LLC | 9089e23e-ca4a-454f-8dcc-ff5a29a5a335 | 2026-09-22 | Warnings, Adverse reactions | 1K09F3G675 |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| Calamine | CALAMINE, ZINC OXIDE | Nice-Pak Products, LLC | c370ee1f-1887-44e8-8d47-8ffa3c270ff5 | 2026-09-15 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | United Natural Foods, Inc. dba UNFI | 0bc1a9b4-1210-4d9a-bbd2-40e9225e86ea | 2026-09-04 | Warnings, Adverse reactions | 1K09F3G675 |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
| BMNP Silicea | SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a58454f-aed6-24ba-e063-6294a90a47fb | 2026-08-31 | Warnings | ETJ7Z6XBU4 |
| Calamine | FERRIC OXIDE RED | Your Military Exchanges | af95a66c-f063-4019-80c6-6f7dc4fee4d8 | 2026-08-28 | Warnings, Adverse reactions | 1K09F3G675 |
| Argentum Quartz | ARGENTUM QUARTZ | Uriel Pharmacy Inc. | 765c8c8f-0727-45da-a77e-c3907a3d0793 | 2026-08-26 | Warnings | ETJ7Z6XBU4 |
| Calamine Plus | CALAMINE, PRAMOXINE HYDROCHLORIDE | Kroger Company | 44fdd5a4-3cac-15e5-e063-6294a90adb52 | 2026-08-26 | Warnings | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.